Insights from ASCO GU: An Exclusive Interview with UBC’s Marie-Pier St-Laurent | Oncology Frontier

Insights from ASCO GU: An Exclusive Interview with UBC’s Marie-Pier St-Laurent | Oncology Frontier

2024.01.31
Welcome to a special feature by Oncology Frontier, where we bridge the gap between continents in the realm of medical innovation. Today, we're honored to host Marie-Pier St-Laurent from the University of British Columbia. As part of our exclusive Specialist Interview series, Marie-Pier will be sharing valuable insights from her recent abstract presented at ASCO GU. Stay tuned as we delve into groundbreaking research that's shaping the future of oncological care. Visit us at www.ioncol.com for more thought-provoking content
Dr. Taisheng Li: The Evolving “Chinese Approach” to HIV/AIDS Diagnosis and Treatment

Dr. Taisheng Li: The Evolving “Chinese Approach” to HIV/AIDS Diagnosis and Treatment

2024.01.24
Editor's Note: Since the discovery of the first AIDS patient in China in 1985, an enduring battle, devoid of gunfire, has persisted for nearly forty years. Generation after generation of Chinese experts in AIDS prevention and control have tirelessly explored a "Chinese approach" to AIDS diagnosis and treatment that suits the national context. With changing treatment models and philosophies, the connotations of the "Chinese approach" to AIDS diagnosis and treatment have continually been updated and enriched. During the recent "21st National Conference on Viral Hepatitis and Liver Diseases, as well as the 2023 Annual Conference of the Chinese Medical Association Hepatology Branch and the Annual Conference of the Chinese Medical Association Infectious Diseases Branch," Dr. Taisheng Li, Director of the Infectious Diseases Branch of the Chinese Medical Association, presented an insightful report on "The Establishment and Application of the 'Chinese Approach' to AIDS Diagnosis and Treatment."
IDWeek Commentary | Dr. Hongmei Xu: CMV PCR Agreement between Blood and Dried Blood Spots in Infants with Congenital Cytomegalovirus Infection

IDWeek Commentary | Dr. Hongmei Xu: CMV PCR Agreement between Blood and Dried Blood Spots in Infants with Congenital Cytomegalovirus Infection

2024.01.23
Infants can be infected with congenital cytomegalovirus (CMV) through vertical mother-to-child transmission, and CMV infection screening is required for some newborns with specific indications. Polymerase chain reaction (PCR) is a commonly used clinical method for qualitative or quantitative diagnosis of CMV, and it can test specimens such as urine, plasma, and dried blood spots, each with its own advantages and disadvantages. A recent study evaluating the consistency of plasma PCR and dried blood spot PCR for CMV infection diagnosis was presented at the 2023 IDWeek. Dr. Hongmei Xu from Children's Hospital of Chongqing Medical University introduces and comments on this study.
ESMO Big Shot Interview | Professor Feng Wang: Significant Efficacy of Sintilimab Combined with Apatinib and Bevacizumab in the Treatment of MSS/pMMR Metastatic Colorectal Cancer, Promising Future

ESMO Big Shot Interview | Professor Feng Wang: Significant Efficacy of Sintilimab Combined with Apatinib and Bevacizumab in the Treatment of MSS/pMMR Metastatic Colorectal Cancer, Promising Future

2024.01.21
The 2023 European Society for Medical Oncology (ESMO) Annual Meeting was held in Madrid, Spain from October 20 to 24. The Oncology Frontier Reporting Team delved into the frontiers of international advancements, witnessing the progress of China's anti-cancer efforts on the global stage. Professor Feng Wang from Sun Yat-sen University Cancer Center presented an important oral report at this conference. In an interview with "Oncology Frontier," Professor Feng Wang shared insights into two studies and highlights in the field of gastric cancer at the ESMO conference. This issue compiles relevant content for readers.